Cargando…

A case report of moderate COVID 19 patient managed through integrative approach (Siddha and conventional medicine)

INTRODUCTION: COVID 19 is a rapidly spreading disease with high mortality and morbidity all over the world which is caused by SARS-COV-2. Siddha system has various formulations with antiviral properties. The study is aimed at evaluating the efficacy of Siddha integrated with conventional medicine fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Neethi, B., Shanmugapriya, P., Janaranjani, G., Gokila, S., Prathisha, B., Jayasree, J.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250905/
https://www.ncbi.nlm.nih.gov/pubmed/35813975
http://dx.doi.org/10.1016/j.jaim.2022.100623
Descripción
Sumario:INTRODUCTION: COVID 19 is a rapidly spreading disease with high mortality and morbidity all over the world which is caused by SARS-COV-2. Siddha system has various formulations with antiviral properties. The study is aimed at evaluating the efficacy of Siddha integrated with conventional medicine for effective management of COVID 19. CASE SUMMARY: A 61 year old male patient diagnosed with COVID was brought in with the complaints of fever, cough, loss of smell, taste, tiredness and breathlessness after 7 days of infection. History revealed that he has not taken any treatment for the past 7 days and therefore presented with pneumonia at the time of consultation. Laboratory investigations showed Neutrophilia, Lymphocytopenia, raised NLR ratio, elevated CRP and D-Dimer. CT chest revealed CORADS-5 and severity score was 10/25. The patient was treated with Siddha medicine from 8 th Day. The patient had taken conventional treatment on 12 th day for 3 days only. Patient showed good improvement on 23 rd day and no adverse effect observed during the course of treatment. CONCLUSION: This case report demonstrates that moderate COVID 19 can be managed with integrative approach.